All Comments by Nikolaos K. Robakis

  1. Peter Davies, Beloved Giant of Alzheimer’s Disease Research, Dies at 72
  2. Melatonin Treatment Enhances Aβ Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis.
  3. Evidence for lymphatic Aβ clearance in Alzheimer's transgenic mice.
  4. Coordination between proteasome impairment and caspase activation leading to TAU pathology: neuroprotection by cAMP.
  5. Testing the right target and right drug at the right stage.
  6. Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration.
  7. Reversing EphB2 depletion rescues cognitive functions in Alzheimer model.
  8. Higher incidence of mild cognitive impairment in familial hypercholesterolemia.
  9. γ-Secretase Drives Spine Formation Via Novel Substrate
  10. Cerebral amyloid angiopathy and parenchymal amyloid deposition in transgenic mice expressing the Danish mutant form of human BRI2.
  11. Presenilin Loss of Function—Plan B for AD?
  12. Protease or Not?—More to Presenilin Toxicity than Meets the (Fly's) Eye
  13. Deletion of presenilin 1 hydrophilic loop sequence leads to impaired gamma-secretase activity and exacerbated amyloid pathology.
  14. Gain or Loss of Function—Time to Shake up Assumptions on γ-Secretase in Alzheimer Disease?
  15. Dangerous Liaisons—Tau and Aβ, Together at Last?